NasdaqGS:APLSBiotechs
A Look At Apellis Pharmaceuticals (APLS) Valuation After Recent S&P Index Additions
Apellis Pharmaceuticals (APLS) has just been added to the S&P 1000, S&P 600, S&P 600 Health Care Sector, and S&P Composite 1500, a shift that can influence trading as index trackers rebalance.
See our latest analysis for Apellis Pharmaceuticals.
Those index additions come after a mixed share price run, with a 90 day share price return of 17.13% contrasting with a year to date share price decline of 12.76% and a 1 year total shareholder return decline of 25.30%. This suggests recent momentum...